155
Participants
Start Date
December 22, 2008
Primary Completion Date
October 13, 2009
Study Completion Date
October 13, 2009
LCI699
LCI699 oral capsules
Eplerenone
Eplerenone oral capsules
LCI699-matching Placebo
LCI699-matching placebo oral capsules
Eplerenone-matching Placebo
Eplerenone-matching placebo oral capsules
New York Cardiovascular Associates, New York
Tipton Medical & Diagnostic Center, Tipton
MD Medical Research, Oxon Hill
Peter A. Holt, Baltimore
Charlotte Clinical Research, Charlotte
Northstate Clinical Research, Lenoir
Medical Research South, Charleston
Mountain View Clinical Research Associates, Greer
Jacksonville Heart Center, Jacksonville Beach
Accelovance, Melbourne
Clinical Research of So. Florida, Coral Gables
Cardio-Pulminary Associates, Plantation
Meridien Research, St. Petersburg
Meridien Research, Bradenton
FPA Clinical Research, Kissimmee
Horizon Research Group, Inc, Mobile
Clinical Research Associates, Inc, Nashville
Community Research, Cincinnati
Accelovance, South Bend
Provident Clinical Research, Bloomington
Chelsea Internal Medicine, Chelsea
Provident Clinical Research, Addison
Cedar-Crosse Research Centereet, Chicago
Punzi Medical Center, Carrollton
KRK Medical Research, Dallas
DCOL Center for Clinical Research, Longview
Metro Clinical Research, Littleton
Northwest Clinical Trials, Boise
Gemini Scientific, Madison
Cochise Clinical Research, Sierra Vista
Clinical Solutions Advantage, Buena Park
Long Beach Center for Clinical Research, Long Beach
Michael Waldman, MD, Irvine
Orange County Research Center, Tustin
Clinical Trials Research, Roseville
Rainier Clinical Research Center, Renton
Daniel Gottlieb, MD, Burien
Encode Clinic, Reykjavik